The Biden administration is expected to approve broader access to extra doses of a COVID-19 vaccine for the general public, not just immunocompromised people, as early as this week.
BOOSTER SHOT ELICITS STRONG IMMUNE RESPONSE TO DELTA VARIANT, PFIZER TELLS FDA
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.